Published in World J Gastroenterol on May 28, 2014
Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain | NCT02613078
Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol (2015) 0.92
Abdominal pain-related functional gastrointestinal disorders based on Rome III criteria in a pediatric gastroenterology clinic. Med J Islam Repub Iran (2015) 0.75
Role of environmental pollution in irritable bowel syndrome. World J Gastroenterol (2015) 0.75
A Review of Research Conducted with Probiotic E. coli Marketed as Symbioflor. Int J Bacteriol (2016) 0.75
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology (2006) 5.73
Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child (1958) 5.49
Peripheral mechanisms in irritable bowel syndrome. N Engl J Med (2012) 3.40
Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr (1996) 2.73
Parent attention versus distraction: impact on symptom complaints by children with and without chronic functional abdominal pain. Pain (2006) 2.62
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics (2010) 2.36
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr (2008) 2.15
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther (2007) 1.92
Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. J Pediatr Gastroenterol Nutr (1995) 1.89
Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2012) 1.80
Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr (2008) 1.77
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil (2005) 1.60
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut (2003) 1.58
Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child (2012) 1.54
Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol (2008) 1.47
Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 1.40
Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology (2007) 1.38
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract (2013) 1.37
Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol (2011) 1.35
The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized, controlled trial. Am J Dis Child (1985) 1.29
Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol (2007) 1.29
VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr (2010) 1.29
Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy. Am J Gastroenterol (2006) 1.27
Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology (2010) 1.27
The epidemiology of recurrent abdominal pain from 2 to 6 years of age: results of a large, population-based study. Pediatrics (2005) 1.22
A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol (2010) 1.19
The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr (2005) 1.17
Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther (2011) 1.15
Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr (1996) 1.14
Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study. J Cardiovasc Pharmacol Ther (2010) 1.14
Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr (2007) 1.13
Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev (2008) 1.12
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev (2007) 1.05
Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2012) 1.05
An epidemiologic study of irritable bowel syndrome in adolescents and children in China: a school-based study. Pediatrics (2005) 1.03
Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev (2009) 1.02
Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil (2011) 1.00
An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol (2010) 0.97
Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci (2010) 0.97
Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev (2008) 0.97
The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment. J Neurogastroenterol Motil (2013) 0.97
Do gut microbial communities differ in pediatric IBS and health? Gut Microbes (2013) 0.95
Audio-recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study. Pediatrics (2009) 0.95
Peppermint oil in irritable bowel syndrome. Phytomedicine (2005) 0.92
Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children. Eur J Pediatr (2004) 0.91
The therapeutic effect of probiotic bacteria on gastrointestinal diseases. Adv Clin Exp Med (2013) 0.91
Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol (2012) 0.90
Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome. J Pain (2012) 0.89
Probiotics for childhood functional gastrointestinal disorders: a systematic review and meta-analysis. Acta Paediatr (2014) 0.89
Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health (2010) 0.89
Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria. J Neurogastroenterol Motil (2012) 0.89
Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome. Rev Gastroenterol Disord (2009) 0.85
Brief hypnotherapeutic-behavioral intervention for functional abdominal pain and irritable bowel syndrome in childhood: a randomized controlled trial. Eur J Pediatr (2013) 0.84
Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern. Saudi J Gastroenterol (2009) 0.84
Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome. Eur Rev Med Pharmacol Sci (2013) 0.84
Relationship between irritable bowel syndrome, worry and stress in adolescent girls. J Korean Med Sci (2012) 0.84
Individual and additive effects of mothers' and fathers' chronic pain on health outcomes in young adults with a childhood history of functional abdominal pain. J Pediatr Psychol (2013) 0.82
A pilot study of yoga treatment in children with functional abdominal pain and irritable bowel syndrome. Complement Ther Med (2011) 0.80
[Comparative study on irritable bowel syndrome treated with acupuncture and western medicine]. Zhongguo Zhen Jiu (2011) 0.80
[Do bulk preparations help in cases of recurrent abdominal pain in children? A controlled study]. Ugeskr Laeger (1982) 0.78
Systematic review of randomized controlled trials: fiber supplements for abdominal pain-related functional gastrointestinal disorders in childhood. Ann Nutr Metab (2012) 0.78
Hypnotherapy: first line treatment for children with irritable bowel syndrome? Arch Dis Child (2013) 0.77
Fructose malabsorption in children with functional digestive disorders. Arq Gastroenterol (2013) 0.77
Hypnosis for functional abdominal pain. Am J Clin Hypn (2011) 0.77
The irritable bowel syndrome. Rocky Mt Med J (1950) 0.76
Stool consistency and abdominal pain in irritable bowel syndrome may be improved by partially hydrolysed guar gum. J Pediatr Gastroenterol Nutr (2011) 0.76
Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial. World J Gastroenterol (2013) 0.76
Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver (2013) 0.76
Controlled outcome studies of child clinical hypnosis. Acta Biomed (2013) 0.76
Partially hydrolyzed guar gum in pediatric functional abdominal pain. World J Gastroenterol (2013) 0.75
Challenges in management of irritable bowel syndrome in children. Indian Pediatr (2013) 0.75